CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 10-K Report Annual Report
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13G Stake Amended Statement of Ownership
- 4 Conversion 10% owner acquired 6,971,912 shares (conversion)
- 4 Conversion 10% owner acquired 1,161,458 shares (conversion)
- 8-K Event Bylaws or fiscal year change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 17,007 shares (conversion)
- 4 Conversion Director acquired 8,243,039 shares (conversion)
- 4 Conversion Director acquired 8,243,039 shares (conversion)
- 4 Conversion 10% owner acquired 8,243,039 shares (conversion)
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 24 of 26 · 514 filings